SEC Form D · Amendment · filed September 1, 2023
Chroma Medicine, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Paola Pozzi · BOSTON, MADirectorGeorge Golumbeski · BOSTON, MADirectorBrett Kaplan · BOSTON, MAExecBihua Chen · BOSTON, MADirectorJeff Marrazzo · BOSTON, MADirectorVic Myer · BOSTON, MAExecKevin Bitterman · BOSTON, MADirectorMichael Kelly · BOSTON, MADirectorCatherine Stehman-Breen · BOSTON, MAExec · DirectorThomas Cahill · BOSTON, MADirectorJamie Brown · Atlanta, GAExecFloretta Gogo · Atlanta, GAExecJonathan S. Spencer · New York, NYDirectorRobin Wilson · St. Helier, Y9DirectorDale J. Dobson · Vancouver, British Columbia, CanadaDirectorTIG Opportunity Partners, LLC · New York, NYDirectorLewis Fellas · St. Helier, Y9Exec · DirectorXavier Carter · Atlanta, GADirectorNicola Harte · St. Helier, Y9DirectorJordan Balencic · Atlanta, GADirectorChris Catalano · Bellmore, NYExecJames Mulvihill · Golden, COExecLiad Meidar · Seattle, WADirectorBrad Harlow · Seattle, WADirectorJamie Brodsky · Port Washington, NYDirectorAmy Springs · Port Washington, NYDirectorDaniel Flannery · Port Washington, NYExec · DirectorChristopher Abbate · Port Washington, NYDirectorRobert C. Manzino · New York, NYDirectorDaniel Calvo · Beverly, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗